T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
26
Marsh
MRSH
$91.7B
| $2.87B | 0.61% |
50,057,427
-146,814
| -0.3% | -$8.05M |
|
27
State Street
STT
$51.6B
| $2.83B | 0.6% |
35,991,158
-470,010
| -1% | -$35.3M |
|
28
Pfizer
PFE
$152B
| $2.74B | 0.58% |
92,672,749
+7,746,765
| +9% | +$222M |
|
|
AGN
29
DELISTED
Allergan plc
AGN
| $2.74B | 0.58% |
10,637,918
+6,638,874
| +166% | +$1.66B |
|
30
ExxonMobil
XOM
$660B
| $2.72B | 0.58% |
29,438,392
+54,086
| +0.2% | +$5.04M |
|
31
Wells Fargo
WFC
$266B
| $2.67B | 0.57% |
48,625,878
-1,639,605
| -3% | -$86.8M |
|
32
American Tower
AMT
$79.6B
| $2.58B | 0.55% |
26,052,382
-4,443,113
| -15% | -$436M |
|
33
Bank of America
BAC
$448B
| $2.57B | 0.55% |
143,492,603
-2,685,434
| -2% | -$46M |
|
34
Bausch Health
BHC
$2.31B
| $2.55B | 0.54% |
17,842,284
+345,074
| +2% | +$46.4M |
|
35
Sherwin-Williams
SHW
$88.5B
| $2.55B | 0.54% |
29,026,950
-5,916,306
| -17% | -$466M |
|
36
Wynn Resorts
WYNN
$10.7B
| $2.54B | 0.54% |
17,047,694
+1,928,744
| +13% | +$331M |
|
37
Salesforce
CRM
$161B
| $2.5B | 0.53% |
42,157,859
+8,325,303
| +25% | +$491M |
|
|
AMTD
38
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.49B | 0.53% |
69,620,185
-5,352,253
| -7% | -$182M |
|
39
AutoZone
AZO
$50.4B
| $2.43B | 0.52% |
3,925,053
-106,785
| -3% | -$60.2M |
|
40
Merck
MRK
$321B
| $2.38B | 0.51% |
43,993,809
-207,985
| -0.5% | -$11.6M |
|
|
FISV
41
Fiserv Inc
FISV
$28B
| $2.37B | 0.5% |
66,812,382
+190,754
| +0.3% | +$6.53M |
|
42
Roper Technologies
ROP
$39.8B
| $2.36B | 0.5% |
15,094,126
+327,513
| +2% | +$50.2M |
|
43
Alibaba
BABA
$307B
| $2.32B | 0.49% |
22,348,104
-4,574,339
| -17% | -$469M |
|
44
Microsoft
MSFT
$3.72T
| $2.32B | 0.49% |
49,948,745
-1,072,202
| -2% | -$50.3M |
|
45
Starbucks
SBUX
$122B
| $2.28B | 0.48% |
55,627,240
-10,037,086
| -15% | -$392M |
|
|
PXD
46
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.23B | 0.47% |
14,966,390
-4,163,612
| -22% | -$687M |
|
|
RHT
47
DELISTED
Red Hat Inc
RHT
| $2.15B | 0.46% |
31,162,763
-1,952,635
| -6% | -$118M |
|
48
CarMax
KMX
$8.33B
| $2.07B | 0.44% |
31,065,243
-3,340,627
| -10% | -$185M |
|
49
Johnson & Johnson
JNJ
$625B
| $2.05B | 0.43% |
19,556,718
-6,187,667
| -24% | -$652M |
|
50
Walt Disney
DIS
$179B
| $2B | 0.42% |
21,211,453
-919,101
| -4% | -$82.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.